DDVAX
Price
$13.58
Change
-$0.31 (-2.23%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

DDVAX vs RMFCX

Header iconDDVAX vs RMFCX Comparison
Open Charts DDVAX vs RMFCXBanner chart's image
Delaware Value® A
Price$13.58
Change-$0.31 (-2.23%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
DDVAX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DDVAX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDVAX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. DDVAX (2.95B). RMFCX pays higher dividends than DDVAX: RMFCX (1.69) vs DDVAX (1.42). DDVAX was incepted earlier than RMFCX: DDVAX (26 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. DDVAX (19.00). RMFCX has a lower initial minimum investment than DDVAX: RMFCX (250) vs DDVAX (1000). RMFCX annual gain was more profitable for investors over the last year : 9.39 vs. DDVAX (-14.61). RMFCX return over 5 years is better than : 36.51 vs. DDVAX (-34.59).
DDVAXRMFCXDDVAX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years23 years-
Gain YTD-15.9898.896-180%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.95B98.7B3%
Annual Yield % from dividends1.421.6984%
Returns for 1 year-14.619.39-156%
Returns for 3 years-30.3611.57-262%
Returns for 5 years-34.5936.51-95%
Returns for 10 years-16.8658.17-29%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.850.02
+2.57%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc